论文部分内容阅读
为进一步探讨睾酮制剂治疗冠心病(CHD)的作用机制,我们观察了长效睾酮制剂Sustanon 250(荷兰Organon公司提供)对老年男性CHD患者血栓素B_2和前列环素(PGI_2)的代谢产物—血栓素B_2(TXB_2)和
To further explore the mechanism of testosterone treatment in patients with coronary heart disease (CHD), we observed the effect of sustained-release testosterone Sustanon 250 (provided by Organon Company in the Netherlands) on thromboxane B_2 and prostacyclin (PGI_2) Prime B_2 (TXB_2) and